Skip to main content

Table 2 Demographic and clinical characteristics of lornoxicam treated and placebo patients

From: Effects of lornoxicam on the physiology of severe sepsis

Characteristic

Lornoxicam group (n = 20)

Placebo group (n = 20)

Age (years [range])

49 (19–87)

51 (20–89)

Sex (male/female)

13/7

9/11

Source of infection

  

Respiratory

15

17

Gastrointestinal

2

1

Blood

2

1

Urinary tract

1

1

APACHE II scorea

17.10 ± 3.58

18 ± 3.72

SOFA scorea

5.90 ± 1.72

6.20 ± 2.2

Duration of ventilationa

6.1 ± 2.4

5.8 ± 3.1

Length of staya

10.2 ± 7.1

9.2 ± 8.4

Mortality rate (%)

35

40

  1. There were no significant differences between the groups. aValues are expressed as mean ± standard deviation. APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sepsis-related (or Sequential) Organ Failure Assessment.
Back to article page

Critical Care

ISSN: 1364-8535